What is Augmedix?
Founded in 2012 and headquartered in San Francisco, California, Augmedix offers a sophisticated platform designed to streamline the medical documentation process. By converting the direct clinician-patient dialogue into accurate medical records, Augmedix addresses a critical pain point in healthcare, allowing clinicians to focus more on patient care and less on administrative tasks. The company's technology aims to improve efficiency, reduce burnout among healthcare professionals, and enhance the overall quality of patient interactions. Its service is particularly valuable in an era of increasing regulatory demands and the need for precise, timely medical record-keeping.
How much funding has Augmedix raised?
Augmedix has raised a total of $155.2M across 11 funding rounds:
Private Equity
$4M
Series A
$16M
Private Equity
$17M
Private Equity
$23M
Series B
$19M
Unspecified
$17M
Debt
$2M
Private Equity
$25M
Unspecified
$17M
Other Financing Round
$12M
Private Equity (2014): $4M led by Emergence Capital Partners and DCM Ventures
Series A (2015): $16M supported by DCM Ventures and Emergence Capital Partners
Private Equity (2016): $17M featuring Redmile Group
Private Equity (2016): $23M backed by OrbiMed, McKesson, DCM Ventures, Redmile Group, and Emergence Capital Partners
Series B (2019): $19M with participation from McKesson, DCM Ventures, and Redmile Group
Unspecified (2019): $17M led by Redmile Group
Debt (2020): $2M supported by PPP
Private Equity (2020): $25M, investors not publicly disclosed
Unspecified (2022): $17M backed by Sutter Health, Redmile Group, Catholic Health Initiatives, Emergence Capital Partners, TriHealth, Dignity Health, and DCM Ventures
Other Financing Round (2023): $12M with participation from Redmile Group and HCA Healthcare
Key Investors in Augmedix
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm focused on the healthcare sector, with deep expertise spanning multiple therapeutic and commercial domains. The firm manages capital across biopharmaceuticals, medical devices, digital health platforms, diagnostics, and healthcare services.
McKesson
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally, operating through distribution and technology solutions segments. The company offers a broad range of healthcare products and services to providers and pharmacies.
DCM Ventures
Digital Cinema Media (DCM) is the market leader in cinema advertising, providing a range of services including campaign planning, production, and audience insights. They cater to brands looking to enhance their advertising strategies through the power of cinema.
What's next for Augmedix?
The recent major strategic investment in Augmedix signals a strong vote of confidence from its backers, positioning the company for its next phase of scaling and market penetration. This capital will likely be directed towards enhancing its technological capabilities, expanding its service offerings, and potentially broadening its geographic reach. As the healthcare industry continues to embrace digital transformation, Augmedix is well-positioned to capitalize on the growing demand for efficient and accurate medical documentation solutions. Future developments may include deeper integration with electronic health record (EHR) systems and the application of advanced AI to further refine its documentation services, solidifying its role as a key player in health information technology.
See full Augmedix company page
